Dementia Incidence in Quebec Over 20 Years

Claire Godard-Sebillotte,Sanjna Navani,Louis Rochette,Victoria Massamba,Éric Pelletier,Edeltraut Kröger,Isabelle Vedel

DOI: https://doi.org/10.1001/jamanetworkopen.2024.47346

2024-12-04

JAMA Network Open

Abstract:This cross-sectional study examines the incidence of dementia from 2003 to 2023 in Quebec, Canada.

medicine, general & internal

What problem does this paper attempt to address?

One-Year Incidence of Psychiatric Disorders in Quebec's Older Adult Population

Michel Préville,Richard Boyer,Helen-Maria Vasiliadis,Sébastien Grenier,Philippe Voyer,Carol Hudon,David L Streiner,John Cairney,Joëlle Brassard,

DOI: https://doi.org/10.1177/070674371005500708

2010-07-01

The Canadian Journal of Psychiatry

Abstract:Objective: To examine the incidence of psychiatric disorders in the Quebec older adult population. Method: Data from the Enquěte sur la Santé des Aînés (ESA) study conducted in 2005 to 2008 using a representative sample (n = 2784) of community-dwelling adults aged 65 years and older were used. Results: The ESA study's results indicate that 12.0% of the respondents met the Diagnostic and Statistical Manual of Mental Disorders (DSM), Fourth Edition, criteria for depression, mania, anxiety disorders, or benzodiazepine drug dependency at the baseline interview. Our results also indicate that the 12-month rate of incident cases of DSM-IV disorders was 6.2%. The proportion of incident cases was higher for the depression group (3.4%) than for the anxiety disorders group (2.3%). The results showed that the probability to develop an incident psychiatric condition after 1 year of follow-up, compared with the noncases group, varied according to sex (OR 2.18; 95% CI 1.39 to 3.44). Our results also showed that the number of chronic health problems (OR 1.20; 95% CI 1.09 to 1.33) and the change in the number of chronic health problems reported between the baseline and the second interview (OR 1.14; 95% CI 1.01 to 1.30) increased the probability to be an incident case at Time 2. The results indicated that social support did not influence the probability to develop a psychiatric disorder. Conclusion: These results indicate that sex and physical health status have an impact on the incidence of DSM-IV disorders in the elderly. This finding underscores the need for improved recognition and treatment of psychiatric disorders associated with physical illness in the older population.
Alzheimer's and other dementias in Canada, 2011 to 2031: a microsimulation Population Health Modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use

Douglas G Manuel,Rochelle Garner,Philippe Finès,Christina Bancej,William Flanagan,Karen Tu,Kim Reimer,Larry W Chambers,Julie Bernier

DOI: https://doi.org/10.1186/s12963-016-0107-z

2016-11-03

Abstract:Background: Worldwide, there is concern that increases in the prevalence of dementia will result in large demands for caregivers and supportive services that will be challenging to address. Previous dementia projections have either been simple extrapolations of prevalence or macrosimulations based on dementia incidence. Methods: A population-based microsimulation model of Alzheimer's and related dementias (POHEM:Neurological) was created using Canadian demographic data, estimates of dementia incidence, health status (health-related quality of life and mortality risk), health care costs and informal caregiving use. Dementia prevalence and 12 other measures were projected to 2031. Results: Between 2011 and 2031, there was a projected two-fold increase in the number of people living with dementia in Canada (1.6-fold increase in prevalence rate). By 2031, the projected informal (unpaid) caregiving for dementia in Canada was two billion hours per year, or 100 h per year per Canadian of working age. Conclusions: The projected increase in dementia prevalence was largely related to the expected increase in older Canadians, with projections sensitive to changes in the age of dementia onset.
Trends in Prevalence of Dementia in French Farmers from Two Epidemiological Cohorts

Karine Pérès,Carol Brayne,Fanny Matharan,Leslie Grasset,Catherine Helmer,Luc Letenneur,Alexandra Foubert-Samier,Isabelle Baldi,François Tison,Hélène Amieva,Jean-François Dartigues

DOI: https://doi.org/10.1111/jgs.14575

Abstract:Objectives: To determine the prevalence of dementia and cognitive impairment in older people across generations. Design: Two prospective cohort studies (Personnes Agées QUID (PAQUID), Aging Multidisciplinary Investigation (AMI)). Setting: Baseline data from two subsamples of older farmers in southwestern France. Participants: PAQUID (n = 595) and AMI (n = 906) participants aged 65 and older living at home at baseline (1988 PAQUID, 2008 AMI). Measurements: Two methods were used to diagnose dementia: a clinical consensus diagnosis and a computer-assisted taxonomy approach (cognitive impairment with disability (CIWD)) using Mini-Mental State Examination and instrumental activity of daily living scores. Crude and standardized prevalences (using PAQUID age-sex structure) and 95% confidence intervals were calculated, and logistic regression was used to explore confounding. Results: The prevalence of consensus diagnosis of dementia was higher in AMI in 2008 than in PAQUID in 1988 (12.0% vs 5.7%, P < .001), whereas the reverse was observed for CIWD (14.8% vs 23.8%, P < .001), confirmed by logistic regressions (odds ratio (OR)AMIvsPAQUID = 2.50, 95% confidence interval (CI) = 1.52-4.12; ORAMIvs.PAQUID = 0.60, 95% CI = 0.42-0.87, respectively). Educational level increased and management of vascular risk factors improved over the study period, and health and living conditions improved globally. Conclusion: These findings suggest global cognitive and functional improvement in old farmers (the prevalence of CIWD decreased by 40% over 20 years) and simultaneously a marked change in the subjective boundary between dementia and nondementia according to clinicians.
Multicenter Validation of the English Version of the Dépistage Cognitif de Québec: a Cognitive Screening Tool for Atypical Dementias

Synthia Meilleur-Durand,Marianne Lévesque,Frederic St-Onge,Mario Masellis,Ging-Yuek Robin Hsiung,Pamela Jarrett,Sylvia Villeneuve,Gabriel Léger,David Salmon,Doug Galasko,Stephen C Cunnane,Serge Gauthier,Brandy Callahan,Leila Sellami,Carol Hudon,Joël Macoir,Louis Verret,Alison Cassivi-Joncas,Michael Comishen,Robert Laforce Jr

DOI: https://doi.org/10.1093/arclin/acae092

2024-10-11

Abstract:Background: Early detection of atypical dementia remains difficult partly because of the absence of specific cognitive screening tools. This creates undue delays in diagnosis and management. The Dépistage Cognitif de Québec (DCQ; dcqtest.org) was developed in French and later validated in participants with atypical syndromes. We report the validation of the English version. Methods: This multicentre prospective validation study was conducted in 10 centers across Canada and the United States on 260 English-speaking participants aged over 50. We translated and modified the original French DCQ to add targeted stimuli to the Visusopatial Index and social cognition vignettes to the Behavioral Index. A backward translation was performed and equivalence between languages was assessed by administering both tests to 30 bilingual participants. Results: Mean DCQ total score (out of 100) was 95.0 (SD = 3.6). Spearman's correlation coefficient showed a strong and significant correlation (r = 0.49, p < .001) with the Montreal Cognitive Assessment. Test-retest reliability was good (Spearman's coefficient = 0.72, p < .001) and interrater reliability, excellent (intraclass correlation = 0.97, p < .001). Normative data shown in percentiles were stratified by age and education for a population-based sample of 260 English-speaking controls aged between 50 and 87 years old. Conclusions: Similar to the French version, the English DCQ proved to be a valid cognitive screening test. The original version was very sensitive to detect atypical dementias such as primary progressive aphasias, Alzheimer's disease' variants and syndromes along the frontotemporolobar degeneration spectrum. This 20-min test can be administered à la carte and offers an alternative to detailed comprehensive neuropsychological evaluations.
A preliminary analysis of incidence of dementia in Shanghai, China

MINGYUAN ZHANG,ROBERT KATZMAN,ELENA YU,WILLIAM LIU,SHI FU XIAO,HEQIN YAN

DOI: https://doi.org/10.1111/j.1440-1819.1998.tb03248.x

1998-12-01

Psychiatry and Clinical Neurosciences

Abstract:The incidence of dementia based on DSM-III criteria and the impact of age and education on the development of dementia using the data of a longitudinal community population survey is discussed. Study subjects were randomly sampled from the community and were assessed by a two-stage procedure twice during a 5-year period. The screening instrument was the Mini-Mental State Examination and the second stage measures include a medical history and physical examination, a neurological examination and an intensive neuropsychiatric interview and testings (i.e. Blessed Dementia Scale, Activity of Daily Living, Fuld Object Memory Test and Block Design Test. All identified cases from the second stage interview were further verified by computed tomographic scan and laboratory tests. A total of 1970 subjects of non-dementia aged 65 or older in 1987 were re-surveyed after 5 years, of whom 114 new cases of dementia were identified. The incidence of dementia in total was 1.15% annually, 0.98% for males and 1.27% for females. The incidence for Alzheimer's disease, vascular dementia and dementia by other causes was 0.74, 0.33 and 0.08%, respectively. The highest rate (2.02%) was found in illiterate individuals. The incidence of dementia in the Shanghai cohort is similar to that from other countries. Age and education are closely related to the occurrence of dementia. While age increases by each 5 years for those aged 65 and over the likelihood of developing dementia increases nearly one-fold (74%). Education shows great protective effect on the development of dementia. The non-educated has a higher risk of suffering from dementia than does the educated.

neurosciences,psychiatry,clinical neurology
Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments

Carrie B Peltz,María M Corrada,Daniel J Berlau,Claudia H Kawas

DOI: https://doi.org/10.1212/WNL.0b013e318238ee89

IF: 9.9

2011-11-22

Neurology

Abstract:Objective: To examine the incidence of dementia among the oldest-old people with normal cognition and different types of cognitive impairment. Methods: This study included 395 participants without dementia (mean age 93.3 years) from The 90+ Study, a prospective, population-based study of aging and dementia in people aged 90 years and older. The participants had evaluations for dementia every 6 months, and their average follow-up was 2.5 years. We examined the incidence of all-cause dementia in participants stratified into 4 cognitive groups: normal, amnestic mild cognitive impairment (aMCI), nonamnestic mild cognitive impairment (naMCI), and other cognitive impairment (OCI). Results: Dementia incidence was highest for participants with aMCI (31.4% per year) and OCI (39.9% per year). Participants with naMCI had an incidence of 14.1% per year, and participants with normal cognition had an incidence of 8.4% per year. Dementia incidence was associated with increasing age in both normal and cognitively impaired participants; however, an APOE4 allele was associated with a higher dementia incidence only in participants with baseline cognitive impairment. Conclusions: The risk of developing dementia in the oldest-old is high and increases to higher rates when cognitive impairment is present. Similar to results of studies in younger elderly individuals, cognitive impairment and increasing age were related to increased dementia incidence. High dementia incidence rates in the oldest-old individuals, particularly when cognitively impaired, emphasize the need to further study cognitive impairment and dementia in this rapidly expanding age group.
More Than the Epidemiology of Alzheimer's Disease: Contributions of the Canadian Study of Health and Aging

Joan Lindsay,Elizabeth Sykes,Ian McDowell,René Verreault,Danielle Laurin

DOI: https://doi.org/10.1177/070674370404900202

2004-02-01

The Canadian Journal of Psychiatry

Abstract:Objective: To highlight contributions to knowledge made by the Canadian Study of Health and Aging (CSHA). Method: The CSHA began in 1991, with follow-ups in 1996 and 2001. It was national in scope, with 18 study centres and a coordinating centre. It included 10 263 participants; of these, 9008 were in the community, and 1255 were in institutions. In each phase, community participants were screened for cognitive impairment, and where appropriate, cognitive status was determined by a detailed clinical examination. Data on possible risk factors for dementia were collected at baseline. Data on caring for people with dementia were collected in each phase. Results: The prevalence of dementia was established at 8% of those aged 65 years and over; incidence (new cases each year) was about 2%. Cognitive impairment not dementia (CIND) was more than twice as common as dementia. Factors affecting the risk of institutionalization, mortality, and the health of caregivers were examined. The costs of dementia were conservatively estimated at $3.9 billion in 1991. Risk factors for Alzheimer's disease (AD) and vascular dementia are presented; it is noteworthy that physical activity appeared to protect against all forms of cognitive decline, particularly for women. Clinical contributions include the development of norms for several neuropsychological tests. Other topics include the health of those with CIND, predicting dementia, medication use, frailty and healthy aging, and urinary incontinence. Conclusion: The CSHA has contributed substantially to knowledge of the epidemiology of dementia, including AD, and to many other topics relevant to seniors' health.
Estimating the Lifetime Risk of Dementia in the Canadian Elderly Population Using Cross-Sectional Cohort Survival Data

Marco Carone,Masoud Asgharian,Nicholas P Jewell,Nicholas P. Jewell

DOI: https://doi.org/10.1080/01621459.2013.859076

IF: 4.369

2014-01-02

Journal of the American Statistical Association

Abstract:Dementia is one of the world's major public health challenges. The lifetime risk of dementia is the proportion of individuals who ever develop dementia during their lifetime. Despite its importance to epidemiologists and policy-makers, this measure does not seem to have been estimated in the Canadian population. Data from a birth cohort study of dementia are not available. Instead, we must rely on data from the Canadian Study of Heath and Aging, a large cross-sectional study of dementia with follow-up for survival. These data present challenges because they include substantial loss to follow-up and are not representatively drawn from the target population because of structural sampling biases. A first bias is imparted by the cross-sectional sampling scheme, while a second bias is a result of stratified sampling. Estimation of the lifetime risk and related quantities in the presence of these biases has not been previously addressed in the literature. We develop and study nonparametric estimators of the lifetime risk, the remaining lifetime risk and cumulative risk at specific ages, accounting for these complexities. In particular, we reveal the fact that estimation of the lifetime risk is invariant to stratification by current age at sampling. We present simulation results validating our methodology, and provide novel facts about the epidemiology of dementia in Canada using data from the Canadian Study of Health and Aging.

statistics & probability
Prevalence and Incidence of Dementia in an Older Chinese Population over Two Decades: the Role of Education.

Ding,Qianhua Zhao,Wanqing Wu,Zhenxu Xiao,Xiaoniu Liang,Jianfeng Luo,Zhen Hong

DOI: https://doi.org/10.1002/alz.12159

2020-01-01

Abstract:Introduction: Secular trends of dementia prevalence and incidence have rarely been studied in the Chinese population. Methods: We examined the changes in dementia prevalence and incidence by comparing data from Shanghai Epidemiological Survey of Dementia and Alzheimer's disease (SESD) and Shanghai Aging Study (SAS) conducted two decades apart. Findings: The dementia prevalence and incidence in total participants in SAS were higher than that in SESD (prevalence: 6.44% vs 2.30%, P < .001; annual incidence: 2.58% vs 1.33%, P < .001). In participants with <= 6 years of education, the dementia prevalence in SAS was higher than that in SESD (6.39% vs 3.07%, P < .001); the annual dementia incidence in SAS was double that in SESD (3.63% vs 1.80%, P = .019). Discussion: We observed an increasing trend of dementia prevalence and incidence in the Chinese elderly, especially those with low education. The dramatic rise in numbers of people with dementia may happen most likely in low-educated populations.
P29: Exploring aging trajectories using neurocognitive age

Élise Roger,Olivier Potvin,Simon Duchesne,Yves Joanette

DOI: https://doi.org/10.1017/s1041610224002126

IF: 7.191

2024-11-29

International Psychogeriatrics

Abstract:Summary: The aging of the population poses significant challenges in healthcare, necessitating innovative approaches. Advancements in brain imaging and artificial intelligence now allow for characterizing an individual's state through their brain age,'' derived from observable brain features. Exploring an individual's biological age'' rather than chronological age is becoming crucial to identify relevant clinical indicators and refine risk models for age-related diseases. However, traditional brain age measurement has limitations, focusing solely on brain structure assessment while neglecting functional efficiency. Our study focuses on developing neurocognitive ages'' specific to cognitive systems to enhance the precision of decline estimation. Leveraging international (NKI2, ADNI) and Canadian (CIMA- Q, COMPASS-ND) databases with neuroimaging and neuropsychological data from older adults [control subjects with no cognitive impairment (CON): n = 1811; people living with mild cognitive impairment (MCI): n = 1341; with Alzheimer's disease (AD): n= 513], we predicted individual brain ages within groups. These estimations were enriched with neuropsychological data to generate specific neurocognitive ages. We used longitudinal statistical models to map evolutionary trajectories. Comparing the accuracy of neurocognitive ages to traditional brain ages involved statistical learning techniques and precision measures. The results demonstrated that neurocognitive age enhances the prediction of individual brain and cognition change trajectories related to aging and dementia. This promising approach could strengthen diagnostic reliability, facilitate early detection of at-risk profiles, and contribute to the emergence of precision gerontology/geriatrics.

psychiatry,geriatrics & gerontology,psychology, clinical,gerontology
20-Year prevalence projections for dementia and impact of preventive policy about risk factors

Hélène Jacqmin-Gadda,Annick Alperovitch,Claire Montlahuc,Daniel Commenges,Karen Leffondre,Carole Dufouil,Alexis Elbaz,Christophe Tzourio,Joël Ménard,Jean-François Dartigues,Pierre Joly

DOI: https://doi.org/10.1007/s10654-013-9818-7

2013-06-01

European Journal of Epidemiology

Abstract:Incidence of dementia increases sharply with age and, because of the increase in life expectancy, the number of dementia cases is expected to rise dramatically over time. Some studies suggest that controlling some modifiable risk factors for dementia like diabetes or hypertension could lower its incidence. However, as treating these vascular factors would also reduce mortality risk, the actual impact of such public-health intervention on dementia prevalence is not known. Accounting for the impact of dementia and risk factors on mortality, the aim of this work was (1) to compute projections of age- and-sex specific prevalence of dementia in France from 2010 to 2030, (2) to evaluate how public-health interventions targeting risk factors for dementia could change these projections. Age-and-sex specific incidence of dementia and mortality of demented subjects were estimated from the Paquid population-based cohort using a semi-parametric illness-death model. Future global mortality rates and population sizes were obtained from national demographic projections. Under the assumption that life expectancy will increase by 3.5 years for men and 2.8 years for women by 2030, the number of subjects with dementia was estimated to increase by about 75 % from 2010 to 2030 with a 200 % increase after 90 years of age. Therapeutic intervention on the whole population reducing high blood pressure prevalence would lead to a decrease in both dementia incidence rates and mortality and would have a modest impact on the number of dementia cases. On the other hand, a preventive dementia treatment targeting ApoE4 carriers would probably not improve survival and hence would decrease dementia prevalence by 15–25 %.

public, environmental & occupational health
Life expectancy and health care utilization of individuals with dementia in Ontario, Canada: A population-level study

Stacey Fisher,Douglas G Manuel,Sarah Spruin,Geoffrey Anderson,Monica Taljaard,Peter Tanuseputro

DOI: https://doi.org/10.23889/ijpds.v5i5.1428

2020-12-07

International Journal of Population Data Science

Abstract:IntroductionIt is important for dementia patients, their families and caregivers, and health planners to have an understanding of life expectancy and the likely care experience of patients from dementia diagnosis to end-of-life. Objectives and ApproachUsing administrative health data of all dementia patients in Ontario, Canada (2014 to 2017) and period life table methodology, life expectancy and average health care use and cost for individuals from dementia diagnosis to death was examined. Dementia was ascertained by a validated case ascertainment definition and information from long-term care, home care and complex continuing care assessments. Formal care was categorized as inpatient, outpatient, home care or long-term care. ResultsLife expectancy at dementia diagnosis was 8.7 years and 9.8 years for men and women diagnosed prior to age 75, of which 3.7 years (42%) and 4.7 years (49%) was spent receiving formal care, respectively. Life expectancy was 4.4 and 5.2 years for men and women diagnosed after age 75, of which 2.2 years (50%) and 3.1 years (60%) was spent receiving care, respectively. Women received proportionally more long-term and home care compared to men, while men received more inpatient and outpatient care. In the year prior to dementia diagnosis, individuals received formal care for 20 days per 100 person-days. Those at the end-of-life received care for 79 days per 100 person-days, including 55 long-term care days and 7.8 inpatient care days. Average direct health care costs from diagnosis to end-of-life was $230,000 and was higer for women and those diagnosed before age 75. ConclusionThe burden of formal care for those with dementia is substantial. The results of this study will be used by physicians to inform conversations with patients, their families and caregivers around what to expect after a dementia diagnosis, and by health care planners for population health planning.
Quality of palliative and end-of-life care: a quantitative study of temporal trends and differences according to illness trajectories in Quebec (Canada)

Arnaud Duhoux,Emilie Allard,Denis Hamel,Martin Sasseville,Sarah Dumaine,Morgane Gabet,Marie-Hélène Guertin

DOI: https://doi.org/10.1186/s12904-024-01403-9

2024-04-11

BMC Palliative Care

Abstract:Our aim was to assess temporal trends and compare quality indicators related to Palliative and End-of-Life Care (PEoLC) experienced by people dying of cancer (trajectory I), organ-failure (Trajectory II), and frailty/dementia (trajectory III) in Quebec (Canada) between 2002 and 2016.

health care sciences & services,health policy & services
Abstract 67: Risk and Time-Course of Post-Stroke Dementia: A Population-Wide Cohort Study, 2002-2022

Raed A Joundi,Jiming Fang,Amy Y Yu,Peter Austin,Eric E Smith,Aravind Ganesh,Luciano Sposato,Vladimir Hachinski,Mukul Sharma,Moira K Kapral

DOI: https://doi.org/10.1161/str.55.suppl_1.67

IF: 10.17

2024-02-01

Stroke

Abstract:Background: People with acute stroke are at high risk of dementia. Population-wide data on the risk and time-course of dementia after stroke are lacking. Methods: We conducted a population-wide analysis of over 15 million people in Ontario, Canada between 2002-2022. Using linked administrative databases, we compared all 90-day survivors of first acute ischemic stroke or intracerebral hemorrhage (ICH) to controls in the general population and with acute myocardial infarction (AMI) by matching 1:1 on age, sex, rural residence, neighborhood marginalization, and vascular comorbidities, and excluded people with prior dementia. We evaluated the rate of dementia per 100 person-years using a validated definition which included hospitalization, physician claims, and medications, and calculated cause-specific hazard ratios overall and across follow-up time. Results: We identified 180,940 people with acute stroke, of which 33,765 (18.7%) developed dementia over mean follow-up of 5.5 years (max 20y). The rate of dementia per 100 person-years was highest after acute stroke compared to the general population (3.40 vs. 1.88) and compared to AMI (3.23 vs. 1.81). The overall risk of dementia was higher in those with acute stroke compared to the general population (HR 1.79, 95% CI 1.76-1.82; Figure 1A), and particularly after ICH (HR 2.43, 2.31-2.57). The results were similar when compared to AMI (HR 1.77, 1.74-1.80; Figure 1C). There was an almost 3-fold elevation of dementia risk in the first year after stroke, decreasing to 1.5-fold by 5 years and remaining elevated even 20 years after (Figure 1B/1D). Conclusion: In this large, population-wide study almost one fifth of people developed dementia after stroke, with an 80% higher risk of developing dementia compared to matched controls. The risk was highest early after stroke but remained elevated 20 years after, raising the urgency of developing interventions for dementia prevention in acute and chronic survivors of stroke.

peripheral vascular disease,clinical neurology
Forecasting the 20-Year Incidence of Dementia by Socioeconomic Status, Race/Ethnicity, and Region Based on Mid-Life Risk Factors in a U.S. Nationally Representative Sample

Nicola Churchill,Deborah E. Barnes,Mina Habib,Roch A. Nianogo

DOI: https://doi.org/10.3233/jad-231133

2024-05-25

Journal of Alzheimer s Disease

Abstract:Background: Alzheimer's disease and related dementias (ADRD) incidence varies based on demographics, but mid-life risk factor contribution to this variability requires more research. Objective: The purpose of this study is to forecast the 20-year incidence of dementia in the U.S. overall and stratified by race/ethnicity, socioeconomic status (SES), and U.S. geographic region given prior mid-life risk factor prevalence and to examine the extent to which risk factor differences 20 years ago may explain current SES, race/ethnicity, or regional disparities in dementia incidence. Methods: We applied the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) prediction model to the 2006 wave of the Health and Retirement Study (HRS) in participants aged 45 to 64 to estimate the 20-year risk of incident ADRD. Results: The 20-year risk of dementia among middle-aged Americans was 3.3% (95% CI: 3.2%, 3.4%). Dementia incidence was forecast to be 1.51 (95% CI: 1.32, 1.71) and 1.27 (95% CI: 1.14, 1.44) times that in Hispanic and Non-Hispanic Black individuals respectively compared statistically to Non-Hispanic White individuals given mid-life risk factors. There was a progressive increase in dementia risk from the lowest versus highest SES quintile. For geographic region, dementia incidence was forecast to be 1.17 (95% CI: 1.06, 1.30) and 1.27 (95% CI: 1.14, 1.43) times that in Midwestern and Southern individuals respectively compared statistically to Western individuals. Conclusions: Some disparities in dementia incidence could be explained by differences in mid-life risk factors and may point toward policy interventions designed to lessen the ADRD disease burden through early prevention.

neurosciences
The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

G. Blessed,B. E. Tomlinson,Martin Roth

DOI: https://doi.org/10.1192/bjp.114.512.797

1968-07-01

Abstract:The ageing of many populations in recent years has directed increasing attention to the social, medical and biological problems of senescence. The psychological changes associated with ageing occupy a central position in inquiries in this field. The expectation of mental disorder shows a steep increase with advancing chronological age, and beyond 75 years a large part of this increase is accounted for by disorders associated with degenerative changes in the central nervous system for which we lack remedies at the present time. Larsson et al . (1963) have estimated that the aggregate morbidity risk for these disorders up to the age of 70 is 0·4 per cent., up to age 75, 1·2 per cent. and up to age 80, 5 per cent. For higher ages estimates were probably less reliable, but the calculated risk up to the age of 90 was 5·2 per cent. In a survey of a random sample of elderly people aged 65 and over in the general population, Kay et al . (1964), found a total of 4·2 per cent. of elderly subjects to be suffering from senile dementia, 2·9 per cent. being mild cases. The condition is generally recognized as being a major cause of serious infirmity among the elderly in psychiatric, geriatric, general medical and community practice alike.

psychiatry
Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services

Janet K Sluggett,Tracy Air,Monica Cations,Gillian E Caughey,Catherine E Lang,Stephanie A Ward,Susannah Ahern,Xiaoping Lin,Kasey Wallis,Maria Crotty,Maria C Inacio

DOI: https://doi.org/10.3233/JAD-230730

Abstract:Background: There is a need for clinical quality indicators (CQIs) that can be applied to dementia quality registries to monitor care outcomes for people with Alzheimer's disease and other forms of dementia. Objective: To develop tertiary and primary care-based dementia CQIs for application to clinical registries for individuals with dementia accessing aged care services and determine 1) annual trends in CQI incidence between 2011-2012 and 2015-2016, 2) associated factors, and 3) geographic and facility variation in CQI incidence. Methods: This retrospective repeated cross-sectional study included non-Indigenous individuals aged 65-105 years who lived with dementia between July 2008-June 2016, were assessed for government-funded aged care services, and resided in New South Wales or Victoria (n = 180,675). Poisson or negative binomial regression models estimated trends in annual CQI incidence and associated factors. Funnel plots examined CQI variation. Results: Between 2011-2012 and 2015-2016, CQI incidence increased for falls (11.0% to 13.9%, adjusted incidence rate ratio (aIRR) 1.05 (95% CI 1.01-1.06)) and delirium (4.7% to 6.7%, aIRR 1.09 (95% CI 1.07-1.10)), decreased for unplanned hospitalizations (28.7% to 27.9%, aIRR 0.99 (95% CI 0.98-0.99)) and remained steady for fracture (6.2% to 6.5%, aIRR 1.01 (95% CI 0.99-1.01)) and pressure injuries (0.5% to 0.4%, aIRR 0.99 (95% CI 0.96-1.02)). Being male, older, having more comorbidities and living in a major city were associated with higher CQI incidence. Considerable geographical and facility variation was observed for unplanned hospitalizations and delirium CQIs. Conclusions: The CQI results highlighted considerable morbidity. The CQIs tested should be considered for application in clinical quality registries to monitor dementia care quality.
Prevalence and population attributable fractions of potentially modifiable risk factors for dementia in Canada: A cross-sectional analysis of the Canadian Longitudinal Study on Aging

Yasaman Dolatshahi,Alexandra Mayhew,Megan E O'Connell,Teresa Liu-Ambrose,Vanessa Taler,Eric E Smith,David B Hogan,Susan Kirkland,Andrew P Costa,Christina Wolfson,Parminder Raina,Lauren Griffith,Aaron Jones

DOI: https://doi.org/10.17269/s41997-024-00920-7

2024-07-24

Can J Public Health

Abstract:Objectives: We investigated the prevalence and population attributable fraction (PAF) of 12 potentially modifiable risk factors for dementia in middle-aged and older Canadians. Methods: We conducted a cross-sectional study of 30,097 adults aged 45 to 85 with baseline data from the Canadian Longitudinal Study on Aging (2011‒2015). Risk factors and associated relative risks were taken from a highly cited systematic review. We calculated the prevalence of each risk factor using sampling weights. Individual PAFs were calculated both crudely and weighted for communality, and combined PAFs were calculated using both multiplicative and additive assumptions. Analyses were stratified by household income and repeated at CLSA's first follow-up (2015‒2018). Results: The most prevalent risk factors were physical inactivity (63.8%; 95% CI, 62.8-64.9), hypertension (32.8%; 31.7-33.8), and obesity (30.8%; 29.7-31.8). The highest crude PAFs were physical inactivity (19.9%), traumatic brain injury (16.7%), and hypertension (16.6%). The highest weighted PAFs were physical inactivity (11.6%), depression (7.7%), and hypertension (6.0%). We estimated that the 12 risk factors combined accounted for 43.4% (37.3‒49.0) of dementia cases assuming weighted multiplicative interactions and 60.9% (55.7‒65.5) assuming additive interactions. There was a clear gradient of increasing prevalence and PAF with decreasing income for 9 of the 12 risk factors. Conclusion: The findings of this study can inform individual- and population-level dementia prevention strategies in Canada. Differences in the impact of individual risk factors between this study and other international and regional studies highlight the importance of tailoring national dementia strategies to the local distribution of risk factors.
Incidence of Dementia Declined in Past 30 Years in US, Study Shows

Susan Mayor

DOI: https://doi.org/10.1136/bmj.i912

2016-01-01

BMJ

Abstract:The incidence of dementia in the United States has declined over the past 30 years, results from the Framingham Heart Study have shown.1 The prevalence of dementia is expected to increase dramatically as the average life expectancy rises, but recent estimates have suggested that the age specific incidence of dementia is actually decreasing in high income countries. To investigate this further, researchers analysed figures from the Framingham Health Study, which has followed participants for incident dementia as part of regular health checks since 1975. The study included 5205 people over 60 who were assessed with the …
Examining trends in dementia incidence and prevalence using an age-period-cohort framework

Kenneth M Langa,Eileen M Crimmins,Mark D Hayward

DOI: https://doi.org/10.1093/med/9780198749493.003.0004

2020-10-01

Abstract:Dementia, a decline in memory and cognition leading to disability in daily function, is a common and feared geriatric condition. Over the past decade, dementia has been the focus of increasing attention from researchers, clinicians, and policymakers due to the projected significant increase in the number of dementia cases expected to result from the worldwide growth in the elderly population. Given the growing evidence that late-life dementia risk likely results from the summation of risk and protective factors that individuals experience across the life course from birth (even pre-birth) through old age, an ‘age-period-cohort’ perspective which clarifies trends in dementia using each of these different lenses may help in identifying potential causal pathways that affect dementia risk. In this chapter, we review recent literature on trends in dementia incidence and prevalence in countries around the world, discuss hypothesized causes for those trends, and present new data on recent trends in dementia incidence and prevalence in the USA.

Dementia Incidence in Quebec Over 20 Years

One-Year Incidence of Psychiatric Disorders in Quebec's Older Adult Population

Alzheimer's and other dementias in Canada, 2011 to 2031: a microsimulation Population Health Modeling (POHEM) study of projected prevalence, health burden, health services, and caregiving use

Trends in Prevalence of Dementia in French Farmers from Two Epidemiological Cohorts

Multicenter Validation of the English Version of the Dépistage Cognitif de Québec: a Cognitive Screening Tool for Atypical Dementias

A preliminary analysis of incidence of dementia in Shanghai, China

Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments

More Than the Epidemiology of Alzheimer's Disease: Contributions of the Canadian Study of Health and Aging

Estimating the Lifetime Risk of Dementia in the Canadian Elderly Population Using Cross-Sectional Cohort Survival Data

Prevalence and Incidence of Dementia in an Older Chinese Population over Two Decades: the Role of Education.

P29: Exploring aging trajectories using neurocognitive age

20-Year prevalence projections for dementia and impact of preventive policy about risk factors

Life expectancy and health care utilization of individuals with dementia in Ontario, Canada: A population-level study

Quality of palliative and end-of-life care: a quantitative study of temporal trends and differences according to illness trajectories in Quebec (Canada)

Abstract 67: Risk and Time-Course of Post-Stroke Dementia: A Population-Wide Cohort Study, 2002-2022

Forecasting the 20-Year Incidence of Dementia by Socioeconomic Status, Race/Ethnicity, and Region Based on Mid-Life Risk Factors in a U.S. Nationally Representative Sample

The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly Subjects

Clinical Quality Indicators for Monitoring Hospitalizations Among Older People with Dementia Accessing Aged Care Services

Prevalence and population attributable fractions of potentially modifiable risk factors for dementia in Canada: A cross-sectional analysis of the Canadian Longitudinal Study on Aging

Incidence of Dementia Declined in Past 30 Years in US, Study Shows

Examining trends in dementia incidence and prevalence using an age-period-cohort framework